Stablix Therapeutics Launches with $63 Million Series A Financing streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stablix Therapeutics launches today with a $63 million series A to bankroll work on protein stabilization in the hopes of treating rare diseases, cancer and immunological disorders.
Author Bio
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi
Like most investors, I m a big fan of gold rushes in new or rapidly expanding industries because that s where there s the most money to be made. When it comes to picking the right stock to benefit from an ongoing gold rush, however, I very much prefer companies that are selling the shovels rather than doing the actual mining. After all, it wouldn t be notable to strike gold if it was a guaranteed outcome, and in innovative new industries, the risk of failure can be quite high.